Revenue - Initiator Pharma A/S (STO:INIT) - Alpha Spread
I

Initiator Pharma A/S
STO:INIT

Watchlist Manager
Initiator Pharma A/S
STO:INIT
Watchlist
Price: 7.35 SEK -2% Market Closed
Market Cap: 388.9m SEK
Have any thoughts about
Initiator Pharma A/S?
Write Note

Initiator Pharma A/S
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Initiator Pharma A/S
Revenue Peer Comparison

Comparables:
GMAB
GLTO
ASND
B
BAVA
BIOPOR

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
I
Initiator Pharma A/S
STO:INIT
Revenue
kr0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Genmab A/S
NASDAQ:GMAB
Revenue
kr19B
CAGR 3-Years
37%
CAGR 5-Years
43%
CAGR 10-Years
39%
Galecto Inc
NASDAQ:GLTO
Revenue
$0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Ascendis Pharma A/S
NASDAQ:ASND
Revenue
€317.6m
CAGR 3-Years
297%
CAGR 5-Years
75%
CAGR 10-Years
32%
B
Bavarian Nordic A/S
CSE:BAVA
Revenue
kr6.1B
CAGR 3-Years
53%
CAGR 5-Years
57%
CAGR 10-Years
19%
Bioporto A/S
CSE:BIOPOR
Revenue
kr33.8m
CAGR 3-Years
11%
CAGR 5-Years
4%
CAGR 10-Years
6%

See Also

What is Initiator Pharma A/S's Revenue?
Revenue
0 DKK

Based on the financial report for Dec 31, 2023, Initiator Pharma A/S's Revenue amounts to 0 DKK.

Back to Top